Crossref
Open-market medicinal plants: A neglected clinical risk
Advances in Integrative Medicine · 2026-12 · 13 (4) · 100699
DOI: 10.1016/j.aimed.2026.100699 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Integrative Medicine, 2026-12. Verfasst von Wael E. Abdalla und 2 weiteren Autor:innen. Die Arbeit nennt 12 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Abdalla, W. E., Sadeek, A. M., & Abdallah, E. M. (2026). Open-market medicinal plants: A neglected clinical risk. Advances in Integrative Medicine, 13(4), 100699. https://doi.org/10.1016/j.aimed.2026.100699
Vancouver
Abdalla WE, Sadeek AM, Abdallah EM. Open-market medicinal plants: A neglected clinical risk. Advances in Integrative Medicine. 2026;13(4):100699. doi:10.1016/j.aimed.2026.100699
BibTeX
@article{Abdalla2026,
author = {Abdalla, Wael E. and Sadeek, Alaa M.M. and Abdallah, Emad M.},
title = {Open-market medicinal plants: A neglected clinical risk},
journal = {Advances in Integrative Medicine},
year = {2026},
volume = {13},
number = {4},
pages = {100699},
doi = {10.1016/j.aimed.2026.100699}
}
EUVIMED